➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Merck
Medtronic
Boehringer Ingelheim
Baxter

Last Updated: September 16, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR WELCHOL

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Welchol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00147719 ↗ WelChol® With Metformin in Treating Patients With Type 2 Diabetes Completed Daiichi Sankyo Inc. Phase 3 2004-06-01 The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to metformin alone or in combination with other anti-diabetic drugs.
NCT00147745 ↗ Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes Completed Daiichi Sankyo Inc. Phase 2 2005-06-01 This study is designed to assess the potential mechanism of action by which WelChol® (colesevelam) may improve blood glucose control in patients with type 2 diabetes
NCT00147758 ↗ WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes Completed Daiichi Sankyo Inc. Phase 3 2004-06-01 The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to sulfonylurea alone or in combination with other anti-diabetic drugs.
NCT00151749 ↗ WelChol® and Insulin in Treating Patients With Type 2 Diabetes Completed Daiichi Sankyo Inc. Phase 3 2004-06-01 The purpose of the study is to see how safe and effective and tolerable the use of WelChol® is for type 2 diabetes when added to insulin alone or in combination with other anti-diabetic drugs
NCT00151762 ↗ Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes Completed Daiichi Sankyo Inc. Phase 3 2004-12-01 This extension study is designed to evaluate the long-term safety and tolerability of colesevelam hydrochloride (WelChol®) in patients with type 2 diabetes.
NCT00185107 ↗ Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol Completed Daiichi Sankyo Inc. Phase 4 2005-03-01 Assess the efficacy of WelChol® plus Zetia® in treating patients with high cholesterol
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Welchol

Condition Name

Condition Name for Welchol
Intervention Trials
Type 2 Diabetes 7
Hypercholesterolemia 5
Type 2 Diabetes Mellitus 4
Dyslipidemia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Welchol
Intervention Trials
Diabetes Mellitus, Type 2 12
Diabetes Mellitus 8
Hypercholesterolemia 5
Hyperlipidemias 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Welchol

Trials by Country

Trials by Country for Welchol
Location Trials
United States 223
Peru 4
Mexico 4
Canada 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Welchol
Location Trials
California 15
Florida 13
Ohio 11
Minnesota 11
Texas 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Welchol

Clinical Trial Phase

Clinical Trial Phase for Welchol
Clinical Trial Phase Trials
Phase 4 12
Phase 3 7
Phase 2/Phase 3 1
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Welchol
Clinical Trial Phase Trials
Completed 22
Recruiting 2
Enrolling by invitation 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Welchol

Sponsor Name

Sponsor Name for Welchol
Sponsor Trials
Daiichi Sankyo Inc. 19
Mayo Clinic 4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Welchol
Sponsor Trials
Industry 25
Other 13
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Medtronic
Colorcon
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.